TrialClinical cancer research : an official journal of the American Association for Cancer Research2022

Phase I/II Trial of Enzalutamide and Mifepristone, a Glucocorticoid Receptor Antagonist, for Metastatic Castration-Resistant Prostate Cancer.

Anthony V Serritella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.